Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study

BACKGROUND AND AIM: We previously reported that vonoprazan-amoxicillin (VA) dual therapy for 7 or 10 days is not satisfactorily efficacious for Helicobacter pylori (H. pylori) eradication. We aimed to explore the efficacy of VA dual therapy for 14 days as a first-line treatment for H. pylori infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yi, Xu, Xin, Liu, Xiao-Shun, He, Cong, Ouyang, Yao-Bin, Li, Nian-Shuang, Xie, Chuan, Peng, Chao, Zhu, Zhen-Hua, Xie, Yong, Shu, Xu, Zhu, Yin, Graham, David Y., Lu, Nong-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885262/
https://www.ncbi.nlm.nih.gov/pubmed/36726990
http://dx.doi.org/10.3389/fimmu.2022.1049908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885262/
https://www.ncbi.nlm.nih.gov/pubmed/36726990
http://dx.doi.org/10.3389/fimmu.2022.1049908

Ejemplares similares